Micelles with ultralow critical micelle concentration as carriers for drug delivery
暂无分享,去创建一个
Wei Wang | Zhiqiang Cao | Ershuai Zhang | Yang Lu | Zhanguo Yue | Wei Wang | Zhiqiang Cao | Yang Lu | Hui Zhu | Zhanguo Yue | Jinbing Xie | Jinbing Xie | Ershuai Zhang | Hui Zhu | Jinbing Xie
[1] N. Turro,et al. Fluorescence Probes for Critical Micelle Concentration , 2001 .
[2] Eric J. Gomez,et al. Tunable Protease-Activatable Virus Nanonodes , 2014, ACS nano.
[3] A. Orlando,et al. COVID-19 in patients with inflammatory bowel disease: A systematic review of clinical data , 2020, Digestive and Liver Disease.
[4] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[5] N. Steinmetz,et al. Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine. , 2015, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[6] Vladimir P Torchilin,et al. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.
[7] M. Yessine,et al. Preparation, characterization, cytotoxicity and biodistribution of docetaxel-loaded polymeric micelle formulations , 2005 .
[8] T. Allen,et al. Insertion of poly(ethylene glycol) derivatized phospholipid into pre‐formed liposomes results in prolonged in vivo circulation time , 1996, FEBS letters.
[9] Craig J Hawker,et al. Cross-linked block copolymer micelles: functional nanostructures of great potential and versatility. , 2006, Chemical Society reviews.
[10] K. Jørgensen,et al. Lipid membrane partitioning of lysolipids and fatty acids: Effects of membrane phase structure and detergent chain length , 2001 .
[11] Vito Pistoia,et al. Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to Chemotherapy , 2012, Science Translational Medicine.
[12] Shaoyi Jiang,et al. Super-hydrophilic zwitterionic poly(carboxybetaine) and amphiphilic non-ionic poly(ethylene glycol) for stealth nanoparticles , 2012 .
[13] Gregory L. Szeto,et al. Structure-based programming of lymph-node targeting in molecular vaccines , 2014, Nature.
[14] Heinz-Bernhard Kraatz,et al. Polymeric micelles as drug delivery vehicles , 2014 .
[15] G. Schwartz,et al. Chemotherapy in the management of advanced cutaneous malignant melanoma. , 2013, Clinics in dermatology.
[16] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[17] R. Chammas,et al. Emerging targets for combination therapy in melanomas , 2015, FEBS letters.
[18] R. Averineni,et al. In Vitro and In Vivo Tumor Growth Inhibition by Glutathione Disulfide Liposomes , 2017, Cancer growth and metastasis.
[19] Li Tang,et al. Smart chemistry in polymeric nanomedicine. , 2014, Chemical Society reviews.
[20] M. Bissery,et al. Docetaxel (Taxotere): a review of preclinical and clinical experience. Part I: Preclinical experience. , 1995, Anti-cancer drugs.
[21] Ick Chan Kwon,et al. Engineered polymers for advanced drug delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[22] Shutao Guo,et al. Nanoparticles containing insoluble drug for cancer therapy. , 2014, Biotechnology advances.
[23] N. Turro,et al. Fluorescence probes for critical micelle concentration determination. , 1985, Langmuir : the ACS journal of surfaces and colloids.
[24] H. Klok,et al. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. , 2001, Advanced drug delivery reviews.
[25] M. Nakagaki,et al. Estimation of critical micelle concentrations of lysolecithins with fluorescent probes. , 1986 .
[26] Pedro M. Valencia,et al. Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation , 2012 .
[27] Nikos Hadjichristidis,et al. Block Copolymers: Synthetic Strategies, Physical Properties, and Applications , 2002 .
[28] K. Miyajima,et al. Quantitative analysis of hemolytic action of lysophosphatidylcholines in vitro: effect of acyl chain structure. , 1988, Chemical & pharmaceutical bulletin.
[29] Teruo Okano,et al. Preparation and Characterization of the Micelle-Forming Polymeric Drug Indomethacin-lncorporated Polyfethylene oxide)-Poly(β-benzyl L-aspartate) Block Copolymer Micelles , 1996 .
[30] K. Ishihara,et al. Synthesis of well-defined amphiphilic block copolymers having phospholipid polymer sequences as a novel biocompatible polymer micelle reagent. , 2005, Biomacromolecules.
[31] R. Kerbel,et al. Effective Treatment of Advanced Human Melanoma Metastasis in Immunodeficient Mice Using Combination Metronomic Chemotherapy Regimens , 2009, Clinical Cancer Research.
[32] J. Rodríguez-Hernández,et al. Toward 'smart' nano-objects by self-assembly of block copolymers in solution , 2005 .
[33] G. Vayssilov,et al. Optimization and in-vitro/in-vivo evaluation of doxorubicin-loaded chitosan-alginate nanoparticles using a melanoma mouse model. , 2019, International journal of pharmaceutics.
[34] A. Oosterom,et al. Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience. , 1995 .
[35] Kinam Park,et al. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Förster resonance energy transfer imaging , 2008, Proceedings of the National Academy of Sciences.
[36] G. Schreiber,et al. Regressions and cures of melanoma xenografts following treatment with monoclonal antibody beta-lactamase conjugates in combination with anticancer prodrugs. , 1995, Cancer research.
[37] H. Weltzien. Cytolytic and membrane-perturbing properties of lysophosphatidylcholine. , 1979, Biochimica et biophysica acta.
[38] D. Newman,et al. Studies on the active site of succinyl-CoA:tetrahydrodipicolinate N-succinyltransferase. Characterization using analogs of tetrahydrodipicolinate. , 1986, The Journal of biological chemistry.
[39] K. Yao,et al. Toward an understanding of thermoresponsive transition behavior of hydrophobically modified N-isopropylacrylamide copolymer solution , 2005 .
[40] A. V. van Oosterom,et al. Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience. , 1995, Anti-cancer drugs.
[41] Jichun Han,et al. Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis , 2016, Scientific Reports.
[42] G. Hortobagyi,et al. Docetaxel for treatment of solid tumours: a systematic review of clinical data. , 2005, The Lancet. Oncology.
[43] Joseph M. DeSimone,et al. Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.
[44] Yuhua Wang,et al. Unmodified drug used as a material to construct nanoparticles: delivery of cisplatin for enhanced anti-cancer therapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[45] Kumiko Okada,et al. Salt Effect on Critical Micelle Concentrations of Nonionic Surfactants, N-Acyl-N-methylglucamides (MEGA-n). , 2001, Journal of colloid and interface science.
[46] C. Tanford,et al. The critical micelle concentration of L- -dipalmitoylphosphatidylcholine in water and water-methanol solutions. , 1972, Journal of molecular biology.
[47] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[48] Lise Arleth,et al. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: effects of PEG chain length and PC incorporation. , 2004, Journal of pharmaceutical sciences.
[49] H. Lee,et al. Stable and efficient delivery of docetaxel by micelle-encapsulation using a tripodal cyclotriphosphazene amphiphile. , 2012, International journal of pharmaceutics.
[50] R. Service. Nanotechnology Takes Aim at Cancer , 2005, Science.
[51] Y. Jeong,et al. Polymeric nanoparticle composed of fatty acids and poly(ethylene glycol) as a drug carrier. , 2003, International journal of pharmaceutics.
[52] T. Andresen,et al. Understanding detergent effects on lipid membranes: a model study of lysolipids. , 2010, Biophysical journal.
[53] G. Piéroni,et al. Observations on the critical micellar concentration of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine and a series of its homologs and analogs. , 1984, Chemistry and physics of lipids.
[54] D. Scheinberg,et al. Conscripts of the infinite armada: systemic cancer therapy using nanomaterials , 2010, Nature Reviews Clinical Oncology.
[55] Yuquan Wei,et al. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. , 2014, Biomaterials.
[56] J. Becker,et al. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene: results from a murine tumour model , 2001, Melanoma research.
[57] D. Maysinger,et al. Polycaprolactone-b-poly(ethylene oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. , 1998, Bioconjugate chemistry.
[58] Numan Hoda,et al. Determination of critical micelle concentration of polybutadiene-block-poly(ethyleneoxide) diblock copolymer by fluorescence spectroscopy and dynamic light scattering , 2013 .
[59] Xiaoling Fang,et al. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation , 2013, International journal of nanomedicine.
[60] Jianbin Huang,et al. Effects of inorganic and organic salts on aggregation behavior of cationic gemini surfactants. , 2010, The journal of physical chemistry. B.
[61] A. Gesquiere,et al. Caveolae-mediated endocytosis of conjugated polymer nanoparticles. , 2013, Macromolecular bioscience.
[62] Qiaobing Xu,et al. Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy. , 2014, Angewandte Chemie.
[63] Xiao-ling Fang,et al. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation , 2013, International journal of nanomedicine.
[64] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.
[65] Shaoyi Jiang,et al. Superhydrophilic zwitterionic polymers stabilize liposomes. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[66] M. Hart,et al. Physical and chemical stability of Taxotere® (docetaxel) one-vial (20 mg/ml) infusion solution following refrigerated storage , 2010, ecancermedicalscience.
[67] J. Gołąb,et al. Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice. , 1998, European journal of cancer.
[68] R. Mumper,et al. A critical review of lipid-based nanoparticles for taxane delivery. , 2013, Cancer letters.
[69] Kinam Park,et al. Overcoming the barriers in micellar drug delivery: loading efficiency, in vivo stability, and micelle–cell interaction , 2010, Expert opinion on drug delivery.
[70] R. Service. Nanotechnology. Nanoparticle Trojan horses gallop from the lab into the clinic. , 2010, Science.
[71] P. Hassan,et al. Self assembled materials: design strategies and drug delivery perspectives. , 2013, Physical chemistry chemical physics : PCCP.
[72] S. Ikeda,et al. Sphere-rod transition of micelles of tetradecyltrimethylammonium halides in aqueous sodium halide solutions and flexibility and entanglement of long rodlike micelles , 1986 .
[73] J. Molina-Bolívar,et al. Effect of ethylene glycol on the thermodynamic and micellar properties of Tween 20 , 2003 .
[74] Andrew L. Ferguson,et al. Investigating the optimal size of anticancer nanomedicine , 2014, Proceedings of the National Academy of Sciences.
[75] Jun Sun,et al. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo. , 2011, European journal of pharmacology.